Trial intelligence / Profile preview

Strontium Ranelate in Primary Knee Osteoarthritis

NCT03937518Completed

Sponsor
Mansoura University
Start
Jul 2018
Primary completion
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of strontium ranelate in knee osteoarthritis (OA), sponsored by Mansoura University. Primary endpoint: Change of pain from baseline at 6 months. Started Jul 2018; status: completed.

02

Drugs

strontium ranelate
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03937518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03937518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call